Leading global ophthalmic CRO Ora announces appointment of pharmaceutical industry veteran Bill Sharbaugh as Chairman of Board of Directors.

Sage Therapeutics is laying off most of its employees after announcing its planned acquisition earlier this month.

Nektar Therapeutics (NASDAQ: NKTR) stock is up around 150% in today’s trading session following the recently announced positive results from its Phase 2b REZOLVE-AD study of rezpegaldesleukin ...

Nektar Therapeutics shares doubled in early trading Tuesday after the U.S. biotech firm said it reached its targets in a midstage study of its eczema treatment.

Eli Lilly LLY 1.34% agreed to acquire Verve Therapeutics VERV -0.37% for about $1 billion upfront, adding a potential treatment for cardiovascular disease to its portfolio. Under the agreement ...

Shares of Verve Therapeutics skyrocketed 75% Tuesday morning after Eli Lilly announced that it would acquire the gene-editing startup for about $1.3 billion.

Turning a $10,000 investment into $1 million represents a financial dream for many — a 100x return that would require an annualized growth rate of approximately 63% over a decade. This level of ...

After dropping its only clinical-stage candidate last month, ADC Therapeutics is shutting down a U.K. research site and laying off 30% of its workforce. | After dropping its only clinical-stage ...

Summit Therapeutics (NASDAQ: SMMT) experienced a significant 30% decrease in its stock on Friday, May 30th, closing at $18. This sudden decline came even though the stock had doubled within the ...

Shape Therapeutics lays off employees, according to posts by former workers on LinkedIn. The cuts come after the company's co-founder stepped down as CEO in October.

She previously served as a board member of Kineta, Proteostasis, and Yumanity Therapeutics. Ms. Drapkin holds a B.S. in Accounting from Babson College.

Beam Therapeutics said it used a form of CRISPR called base editing to correct, in several patients, a mutation that drives a debilitating lung condition.